about
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of mon...
Read More
4.13
0.57
(16.01%)
388.1K
XNAS Volume
High vol.+gain this week
XNAS 13 Mar, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Adagene Inc (ADR) is on 24 Mar 2026 for the purpose of Adagene Inc Fourth Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Bullish
Adagene Inc (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..